6515--Dexcom Continuous Glucose Monitoring System
36C24625Q0894 · VETERANS AFFAIRS, DEPARTMENT OF
A IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING solicitation, with responses due 2025-07-17. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
36C24625Q0894 Page 1 of Page 52 of 52 Page 1 of RFQ 36C24625Q0894 - Dexcom, Continuous Glucose Monitoring System
Comparable recent awards in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| REMEL INC. | $64K | n/a | 2026-07-02 |
| CEPHEID | $306K | n/a | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $2.8M | n/a | 2026-07-01 |
| BECTON, DICKINSON AND COMPANY | $21K | 1 | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $102K | 1 | 2026-07-01 |
Questions
What is solicitation 36C24625Q0894?
6515--Dexcom Continuous Glucose Monitoring System, issued by VETERANS AFFAIRS, DEPARTMENT OF, under NAICS 325413 (IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING). Responses are due 2025-07-17.
What do similar contracts close for?
Comparable closed awards in this category ran from $21K to $2.8M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.